Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,343,106
+$679,430 QoQ
Shares Held
29,181
-4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#1,076
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOWE BROCKENBROUGH & CO INC holds $62,097,620 across 10 Drug Manufacturers - General names. ABBV ranks #5 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,660 | $12,104,210 | |
| 2 | MRK |
Merck & Co., Inc.
|
91,716 | $11,785,506 | |
| 3 | LLY |
ELI LILLY & Co
|
8,214 | $9,852,118 | |
| 4 | AMGN |
Amgen Inc
|
26,947 | $9,758,047 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
29,181 | $7,343,106 | |
| 6 | PFE |
Pfizer Inc
|
216,527 | $5,213,970 | |
| 7 | NVS |
Novartis AG
|
13,636 | $2,137,033 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,635 | $1,880,428 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,343,106 | 29,181 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $6,663,676 | 30,639 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,165,674 | 31,361 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,346,995 | 31,731 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,909,212 | 31,835 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,397,064 | 30,532 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,484,710 | 30,865 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,175,989 | 31,274 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,626,752 | 26,975 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,142,321 | 28,239 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,197,538 | 33,539 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,759,336 | 31,929 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,951,866 | 36,754 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,852,863 | 36,725 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,569,403 | 34,462 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,967,112 | 37,010 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $5,619,287 | 36,689 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $5,974,564 | 36,855 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $5,180,945 | 38,264 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,127,537 | 38,264 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,904,232 | 43,539 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,728,564 | 43,694 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,705,492 | 43,915 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,901,258 | 44,540 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,372,740 | 44,538 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,361,883 | 44,125 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||